NCT01014065View on ClinicalTrials.gov

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

January 31, 2013

Conditions
Renal Cell CarcinomaCardiotoxicityHeart FailureHypertension
Trial Locations (1)

Unknown

University of Alberta/ Cross Cancer Institute, Edmonton

All Listed Sponsors
collaborator

Cross Cancer Institute

OTHER

lead

AHS Cancer Control Alberta

OTHER

NCT01014065 - A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) | Biotech Hunter | Biotech Hunter